Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

Download this application note to learn more about targeted sequencing approaches such as RNA exome sequencing. Is the form ...

TheFly reported on April 10 that Piper Sandler began coverage of CAI with a Neutral rating and a $21 price target.

Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on interoperability are the major factors which drive global market growth.WILMIN ...

According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.

(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications ...

Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not simply shut down during winter. Instead, they remain developmentally active, ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the launch of a groundbreaking AI-driven molecular ...